Search Results - "Strijbis, Eva M. M."

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go? by Strijbis, Eva M M, Kerbrat, Anne, Corboy, John R

Get more information

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis by Noteboom, Samantha, Seiler, Moritz, Chien, Claudia, Rane, Roshan P., Barkhof, Frederik, Strijbis, Eva M. M., Paul, Friedemann, Schoonheim, Menno M., Ritter, Kerstin

“…Background Robust predictive models of clinical impairment and worsening in multiple sclerosis (MS) are needed to identify patients at risk and optimize…”
Get full text

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort by van Kempen, Zoé L E, Strijbis, Eva M M, Al, Marissa M C T, Steenhuis, Maurice, Uitdehaag, Bernard M J, Rispens, Theo, Killestein, Joep

Get more information

The role of CD56bright NK cells in neurodegenerative disorders by Rodriguez-Mogeda, Carla, van Ansenwoude, Chaja M. J, van der Molen, Lennart, Strijbis, Eva M. M, Mebius, Reina E, de Vries, Helga E

“…Abstract Emerging evidence suggests a potential role for natural killer (NK) cells in neurodegenerative diseases, such as multiple sclerosis, Alzheimer’s…”
Get full text

Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis by Molenaar, Pam C. G., Noteboom, Samantha, van Nederpelt, David R., Krijnen, Eva A., Jelgerhuis, Julia R., Lam, Ka-Hoo, Druijff-van de Woestijne, Gerrieke B., Meijer, Kim A., van Oirschot, Pim, de Jong, Brigit A., Brouwer, Iman, Jasperse, Bas, de Groot, Vincent, Uitdehaag, Bernard M. J., Schoonheim, Menno M., Strijbis, Eva M. M., Killestein, Joep

“…Background Digital monitoring of people with multiple sclerosis (PwMS) using smartphone-based monitoring tools is a promising method to assess disease activity…”
Get full text

Adipokines in multiple sclerosis patients are related to clinical and radiological measures by Loonstra, Floor C., Falize, Kim F., de Ruiter, Lodewijk R. J., Schoonheim, Menno M., Strijbis, Eva M. M., Killestein, Joep, de Vries, Helga E., Uitdehaag, Bernard M. J., Rijnsburger, Merel

“…Background An imbalance of adipokines, hormones secreted by white adipose tissue, is suggested to play a role in the immunopathology of multiple sclerosis…”
Get full text

Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination by Ghorbani, Samira, Jelinek, Emily, Jain, Rajiv, Buehner, Benjamin, Li, Cenxiao, Lozinski, Brian M., Sarkar, Susobhan, Kaushik, Deepak K., Dong, Yifei, Wight, Thomas N., Karimi-Abdolrezaee, Soheila, Schenk, Geert J., Strijbis, Eva M., Geurts, Jeroen, Zhang, Ping, Ling, Chang-Chun, Yong, V. Wee

“…Remyelination failure in multiple sclerosis (MS) contributes to progression of disability. The deficient repair results from neuroinflammation and deposition…”
Get full text

Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications by Kooi, Evert-Jan, Strijbis, Eva M.M., van der Valk, Paul, Geurts, Jeroen J.G.

“…OBJECTIVE:Autopsy cases show that cortical lesions (CLs) in multiple sclerosis (MS) lack lymphocyte/macrophage influx, blood-brain barrier breakdown, and…”
Get full text

Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study by Kaçar, Sezgi, Coric, Danko, Ometto, Giovanni, Montesano, Giovanni, Denniston, Alastair K, Keane, Pearse A, Uitdehaag, Bernard M J, Crabb, David P, Schoonheim, Menno M, Petzold, Axel, Strijbis, Eva M M

“…The glymphatic system removes neurodegenerative debris. The ocular glymphatic outflow is from the eye to the proximal optic nerve. In multiple sclerosis (MS),…”
Get full text

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination by van Dam, Koos P. J., Hogenboom, Laura, Stalman, Eileen W., Kummer, Laura Y. L., Steenhuis, Maurice, Keijser, Jim B. D., Brinke, Anja ten, van Ham, S. Marieke, Kuijpers, Taco W., Rispens, Theo, Wieske, Luuk, Eftimov, Filip, Strijbis, Eva M., Killestein, Joep, van Kempen, Zoé L. E.

“…Introduction During the COVID-19 pandemic, certain disease modifying therapies (DMTs) used in multiple sclerosis (MS), such as anti-CD20 therapies, have been…”
Get full text

Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination by Huitema, Marije J D, Strijbis, Eva M M, Luchicchi, Antonio, Bol, John G J M, Plemel, Jason R, Geurts, Jeroen J G, Schenk, Geert J

“…Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the central nervous system (CNS). Repair through remyelination can be extensive,…”
Get full text

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis by Horjus, Julia, van Mourik-Banda, Tineke, Heerings, Marco A. P., Hakobjan, Marina, De Witte, Ward, Heersema, Dorothea J., Jansen, Anne J., Strijbis, Eva M. M., de Jong, Brigit A., Slettenaar, Astrid E. J., Zeinstra, Esther M. P. E., Hoogervorst, Erwin L. J., Franke, Barbara, Kruijer, Wiebe, Jongen, Peter J., Visser, Leo J., Poelmans, Geert

“…Multiple sclerosis (MS) is a degenerative disease of the central nervous system in which auto-immunity-induced demyelination occurs. MS is thought to be caused…”
Get full text

State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network Analyses by Strijbis, Eva M. M., Timar, Yannick S. S., Schoonhoven, Deborah N., Nauta, Ilse M., Kulik, Shanna D., de Ruiter, Lodewijk R. J., Schoonheim, Menno M., Hillebrand, Arjan, Stam, Cornelis J.

“…Background A common problem in resting-state neuroimaging studies is that subjects become drowsy or fall asleep. Although this could drastically affect…”
Get full text

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis by Coerver, Eline M. E., Strijbis, Eva M. M., Petzold, Laura F., Van Kempen, Zoé L. E., Jasperse, Bas, Barkhof, Frederik, Oudejans, Cees B. M., Uitdehaag, Bernard M. J., Teunissen, Charlotte E., Killestein, Joep

“…Background Myxovirus resistance protein A (MxA) is a protein that is upregulated by interferon-beta. Homeostatic MxA mRNA levels are potentially correlated…”
Get full text

How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice? by Palladino, Raffaele, Strijbis, Eva M M

Get full text

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort by Loonstra, Floor C., Ruiter, Lodewijk R. J., Schoonheim, Menno M., Moraal, Bastiaan, Strijbis, Eva M. M., Jong, Brigit A., Uitdehaag, Bernard M. J.

“…Objective To examine (1) the association between childhood diet and developing MS, age of onset and onset type and (2) the association between diet at age 50…”
Get full text

Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis by Strijbis, Eva M.M., Koch, Marcus W.

Get full text

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis by Vennegoor, Anke, Rispens, Theo, Strijbis, Eva MM, Seewann, Alexandra, Uitdehaag, Bernard MJ, Balk, Lisanne J, Barkhof, Frederik, Polman, Chris H, Wolbink, Gertjan, Killestein, Joep

“…Background: Antibodies against natalizumab have been found in 4.5–14.1% of natalizumab-treated multiple sclerosis (MS) patients. If antibodies persist, they…”
Get full text

Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia by Strijbis, Eva M M, Oudman, Inge, van Essen, Phillipa, MacLennan, Alastair H

“…To apply objective criteria for the identification of acute intrapartum hypoxia in a cohort of cerebral palsy cases and to identify other cerebral…”
Get full text

Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis by Lemmens, Cynthia M C, van Amerongen, Suzan, Strijbis, Eva M, Killestein, Joep

“…Outcome reporting bias occurs when publication of trial results is dependent on clinical significance, thereby threatening the validity of trial results…”
Get full text